单位:[1]Clinical Research Center,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology (HUST),Wuhan,China华中科技大学同济医学院附属同济医院[2]Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, HUST, Wuhan, China[3]Department of Neurology,Tongji Hospital,Tongji Medical College,HUST,Wuhan,China华中科技大学同济医学院附属同济医院神经内科神经科[4]Institute and Department of Infectious Disease,Tongji Hospital,Tongji Medical College,HUST,Wuhan,China华中科技大学同济医学院附属同济医院感染科[5]Department of Laboratory Medicine,Tongji Hospital,Tongji Medical College,HUST,Wuhan,China华中科技大学同济医学院附属同济医院检验科
Background: Low vitamin D (VitD) status is becoming a global health issue. Previous heterogenous results are urging a meta-analysis to delineate a panorama of VitD conditions in the general population in Mainland of China. Methods: We performed a systematic review and meta-analysis by searching PubMed, Web of Science, EMBASE, China National Knowledge Infrastructure, WanFang, and VIP databases up to June 4, 2021. The inclusion criteria were as follows: (1) original articles or dissertations focused on VitD status of people in Mainland of China; and (2) studies were population-based, cross-sectional, or longitudinal cohort with baseline data. The outcomes were serum 25(OH)D concentration and the prevalence of low VitD status. Low VitD status included VitD deficiency (< 30 nmol/L) and VitD inadequacy (< 50 nmol/L). Data were estimated by Hierarchical Bayesian methods. All included studies were cross-sectional or longitudinal cohort studies about VitD status of people in Mainland of China. (Registration: PROSPERO CRD42021226130). Findings: A total of 105 eligible studies including 234,519 subjects were included. In adults, the overall mean 25(OH)D concentration was 44.3 nmol/L (95% Credible Interval [CrI]: 39.8-48.7). The pooled prevalence of VitD deficiency and inadequacy was 20.7% (95% CrI: 11.9-32.9) and 63.2% (95% CrI: 53.5-72.3), respectively. In children and adolescents, the overall mean 25(OH)D concentration was 52.2 nmol/L (95% CrI: 46.7-57.5). The pooled prevalence of VitD deficiency and inadequacy was 23.0% (95% CrI: 8.9-44.3) and 46.8% (95% CrI: 37.2-56.6), respectively. Specially, we identified that the prevalence of VitD inadequacy increased with age in populations with age < 18 years and > 60 years. Interpretation: Low VitD status is prominent in general population of Mainland of China, especially for adults. Funding: National Major Scientific and Technological Special Project for "Significant New Drugs Development" (2017ZX09304022). (c) 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
基金:
National Major Scientific and Tech-nological Special Project for "Significant New Drugs Development" [2017ZX09304022]
第一作者单位:[1]Clinical Research Center,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology (HUST),Wuhan,China
通讯作者:
推荐引用方式(GB/T 7714):
liu wenhua,hu jing,fang yuanyuan,et al.Vitamin D status in Mainland of China: A systematic review and meta- analysis[J].ECLINICALMEDICINE.2021,38:doi:10.1016/j.eclinm.2021.101017.
APA:
liu,wenhua,hu,jing,fang,yuanyuan,wang,peng,lu,yanjun&shen,na.(2021).Vitamin D status in Mainland of China: A systematic review and meta- analysis.ECLINICALMEDICINE,38,
MLA:
liu,wenhua,et al."Vitamin D status in Mainland of China: A systematic review and meta- analysis".ECLINICALMEDICINE 38.(2021)